Mercuric chloride API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Mercuric chloride is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Mercuric chloride or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Mercuric chloride API 7487-94-7?

Description:
Here you will find a list of producers, manufacturers and distributors of Mercuric chloride. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Mercuric chloride 
Synonyms:
bichlorure de mercure , chlorure mercurique , corrosive mercury chloride , corrosive sublimate , dichloromercury , dichlorure de mercure , hydrargyrum bichloratum , mercuric bichloride , mercury bichloride , mercury perchloride , Mercury(II) chloride , Quecksilber(II)-chlorid , Sublimat , sublimate , Sulema  
Cas Number:
7487-94-7 
DrugBank number:
DB13765 
Unique Ingredient Identifier:
53GH7MZT1R

General Description:

Mercuric chloride, identified by CAS number 7487-94-7, is a notable compound with significant therapeutic applications. Mercury chloride (HgCl2) is a highly toxic compound that volatizes slightly at ordinary temperature and appreciably at 100 degrees C. It is corrosive to mucous membranes and used as a topical antiseptic and disinfectant. Mercuric chloride was used to disinfect wounds by Arab physicians in the Middle Ages but modern medicine has since deemed it unsafe for use.

Classification:

Mercuric chloride belongs to the class of inorganic compounds known as transition metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is a transition metal, classified under the direct parent group Transition metal chlorides. This compound is a part of the Inorganic compounds, falling under the Mixed metal/non-metal compounds superclass, and categorized within the Transition metal salts class, specifically within the Transition metal chlorides subclass.

Categories:

Mercuric chloride is categorized under the following therapeutic classes: Anti-Infective Agents, Anti-Infective Agents, Local, Antiseptics and Disinfectants, Chlorides, Chlorine Compounds, Compounds used in a research, industrial, or household setting, Dermatologicals, Disinfectants, Mercurial Products, Mercury Compounds. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Mercuric chloride is a type of Anti-infective Agents


Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.

Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.

The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.

The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.

In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.